ANANTA PANDIT: Open Payments
NPI 1073826327 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 19 payments from 7 companies in 2025. Trend: 2023 $607 · 2024 $759 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $166 |
| Regeneron Healthcare Solutions, Inc. | 1 | $134 |
| Novo Nordisk Inc | 2 | $36 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| PFIZER INC. | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: MOUNJARO, DUPIXENT, SHINGRIX, Ozempic, ELIQUIS, EVENITY, Kerendia.
Industry payments across IL — which companies pay providers there.
